| |
| |
|
| Insider
Information: |
Behrens M Kathleen |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
347,857 |
|
|
Indirect Shares
|
400,313 |
|
|
| Direct
Value |
$24,324,930 |
|
|
|
Indirect Value
|
$1,309,000 |
|
|
| Total
Shares |
748,170 |
|
|
| Total
Value |
$25,633,930 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -4.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sarepta Therapeutics Inc |
SRPT |
|
2024-03-01 |
176,839 |
2024-03-01 |
10,000 |
Premium* |
|
|
Amylin Pharmaceuticals Inc |
AMLN |
Director |
2012-08-08 |
0 |
2011-05-24 |
0 |
Premium* |
|
|
Igm Biosciences, Inc. |
IGMS |
|
2024-03-29 |
10,046 |
2024-03-29 |
390,313 |
Premium* |
|
|
Mimedx Group Inc |
MDXG |
Director |
2023-06-13 |
160,972 |
2020-08-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IGMS |
Igm Biosciences, Inc. |
|
– • – |
2024-03-29 |
4 |
A |
$0.00 |
$0 |
D/D |
3,078 |
10,046 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
|
– • – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,846 |
176,839 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2023-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
800 |
6,968 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2023-11-03 |
4 |
OE |
$29.03 |
$435,450 |
D/D |
15,000 |
174,993 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2023-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
800 |
6,168 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2023-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
800 |
5,368 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2023-06-26 |
4 |
B |
$8.00 |
$900,000 |
I/I |
112,500 |
330,700 |
2.1 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2023-06-13 |
4 |
A |
$4.95 |
$175,002 |
D/D |
35,354 |
160,972 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,523 |
159,993 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
374 |
3,768 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2022-12-19 |
4 |
OE |
$34.92 |
$698,400 |
D/D |
20,000 |
158,470 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-11-08 |
4 |
B |
$17.14 |
$1,028,550 |
I/I |
60,000 |
218,200 |
2.1 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
374 |
3,394 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
374 |
3,020 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2022-06-07 |
4 |
A |
$3.96 |
$174,996 |
D/D |
44,191 |
125,618 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-04-01 |
4 |
B |
$23.00 |
$1,399,987 |
I/I |
60,869 |
29,806 |
2.1 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
374 |
2,646 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2022-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,953 |
138,470 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2021-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
211 |
2,272 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2021-12-15 |
4 |
OE |
$10.08 |
$50,400 |
D/D |
5,000 |
135,517 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2021-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
211 |
2,061 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
211 |
1,850 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2021-05-27 |
4 |
A |
$10.26 |
$174,995 |
D/D |
17,056 |
81,427 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2021-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
211 |
94,139 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2021-03-10 |
4 |
S |
$85.76 |
$428,800 |
D/D |
(5,000) |
130,517 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
